Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.

OBJECTIVE To assess the risk of incident diabetes mellitus (DM) in patients with psoriasis and to evaluate DM treatment patterns among patients with psoriasis and incident DM. DESIGN Population-based cohort study. SETTING United Kingdom-based electronic medical records. PATIENTS We matched 108 132 patients with psoriasis aged 18 to 90 years with 430 716 unexposed patients based on practice and time of visit. For our nested study, only patients who developed incident DM during our study time were included. MAIN OUTCOME MEASURES Incident DM and adjusted risk of pharmacotherapy among those with incident DM. RESULTS The fully adjusted hazard ratios (95% CIs) for incident DM were 1.14 (95% CI, 1.10-1.18), 1.11 (95% CI, 1.07-1.15), and 1.46 (95% CI, 1.30-1.65) in the overall, mild, and severe psoriasis groups, respectively. Among those with incident DM and severe psoriasis, the adjusted risk for receiving DM pharmacotherapy was 1.55 (95% CI, 1.15-2.10). CONCLUSIONS Our results suggest that psoriasis is an independent risk factor for the development of type 2 DM in a dose-dependent manner, and that patients with severe psoriasis who develop DM are more likely to receive systemic diabetic therapies in comparison with patients with DM but without psoriasis.

[1]  D. Margolis,et al.  Validity of The Health Improvement Network (THIN) for the study of psoriasis , 2011, The British journal of dermatology.

[2]  David J Margolis,et al.  Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. , 2004, The journal of investigative dermatology. Symposium proceedings.

[3]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[4]  B. Gersh.  Risk of Myocardial Infarction in Patients With Psoriasis , 2007 .

[5]  A. Kimball,et al.  Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002 , 2008, Dermatology.

[6]  Evangelos Kontopantelis,et al.  Pay-for-performance programs in family practices in the United Kingdom. , 2006, The New England journal of medicine.

[7]  A. Troxel,et al.  Cause‐specific mortality in patients with severe psoriasis: a population‐based cohort study in the U.K. , 2010, The British journal of dermatology.

[8]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[9]  Herng‐Ching Lin,et al.  Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. , 2011, Journal of the American Academy of Dermatology.

[10]  L. Skov,et al.  Prognosis following first‐time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study , 2011, Journal of internal medicine.

[11]  Javier Martín,et al.  High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. , 2007, Arthritis and rheumatism.

[12]  O. Karabudak,et al.  Noninvasive assessment of impaired endothelial function in psoriasis , 2010, Rheumatology International.

[13]  B. Lindegård.  Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. , 1986, Dermatologica.

[14]  C. Moorehead.  All rights reserved , 1997 .

[15]  Y. Altuntas,et al.  Comparison of various insulin sensivity indices in psoriatic patients and their relationship with type of psoriasis , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  J. Meyerovitch,et al.  Association between Psoriasis and the Metabolic Syndrome , 2008, Dermatology.

[17]  Andrea B Troxel,et al.  The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. , 2010, Archives of dermatology.

[18]  E. Christophers,et al.  Disease concomitance in psoriasis. , 1995, Journal of the American Academy of Dermatology.

[19]  A. Alavi,et al.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. , 2011, Archives of dermatology.

[20]  A. Troxel,et al.  The risk of stroke in patients with psoriasis. , 2009, The Journal of investigative dermatology.

[21]  B. Thiers.  Psoriasis and the risk of incident diabetes mellitus: a population-based study , 2009 .

[22]  K. Khunti,et al.  Prevalence of diagnosed diabetes mellitus in general practice in England and Wales, 1994 to 1998 , 2002 .

[23]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[24]  R. Akdemir,et al.  Impaired aortic elasticity in patients with psoriasis , 2009, Acta cardiologica.

[25]  O. Deveci,et al.  Is psoriasis a pre‐atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis , 2010, International journal of dermatology.

[26]  D. Margolis,et al.  Association Between Renal Failure and Foot Ulcer or Lower-Extremity Amputation in Patients With Diabetes , 2008, Diabetes Care.

[27]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[28]  Y. Tu,et al.  Prevalence of myocardial infarction in patients with psoriasis in central China , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[29]  P. Gisondi,et al.  Chronic Plaque Psoriasis Is Associated with Increased Arterial Stiffness , 2008, Dermatology.

[30]  S. Jick,et al.  Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case–control analysis , 2009, The British journal of dermatology.

[31]  Andrea B Troxel,et al.  The risk of mortality in patients with psoriasis: results from a population-based study. , 2007, Archives of dermatology.

[32]  J. Koo.  Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. , 1996, Dermatologic clinics.

[33]  B. Tom,et al.  Cardiovascular morbidity in psoriatic arthritis , 2008, Annals of the rheumatic diseases.

[34]  J. Q. Rosso,et al.  Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality , 2010 .

[35]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[36]  P. Hutchinson,et al.  Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease , 1996, The British journal of dermatology.

[37]  C. Herzog,et al.  Psoriasis: a possible risk factor for development of coronary artery calcification , 2007, The British journal of dermatology.

[38]  K. Badenhoop,et al.  Psoriasis patients show signs of insulin resistance , 2007, The British journal of dermatology.

[39]  J. Gelfand,et al.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. , 2009, Journal of the American Academy of Dermatology.

[40]  D. Margolis,et al.  Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. , 2005, Archives of dermatology.

[41]  S. El-Mongy,et al.  Subclinical atherosclerosis in patients with chronic psoriasis: a potential association , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  Andrea B Troxel,et al.  Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.

[43]  L. Skov,et al.  Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study , 2011, Journal of Internal Medicine.

[44]  N. Glorioso,et al.  High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. , 1985, Acta cardiologica.

[45]  A. Qureshi,et al.  Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. , 2009, Archives of dermatology.